A retrospective cohort of 39 patients with BRAF-mutant NSCLC (21 V600E- and 18 non-V600E) was recently reported, showing that 45% of patients had high PDL-1 expression (>50%) [86]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.